Allergy Therapeutics PLC Stock
Price
Target price
€0.030
€0.030
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Allergy Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allergy Therapeutics PLC | - | 9.259% | 7.273% | -37.895% | 37.209% | -87.174% | - |
| Alliance Pharma plc | -0.510% | -4.902% | -11.009% | -39.845% | -3.960% | -64.404% | - |
| Cellectar BioSciences Inc. | 3.550% | -1.389% | -21.547% | 111.940% | 24.561% | -77.097% | - |
| Beximco Pharmaceuticals Ltd. GDR | -0.930% | -5.333% | -2.294% | -5.333% | -3.182% | -55.158% | -23.929% |
News
Is AT&T a Buy Now?
Shares of AT&T (NYSE: T) recently slipped about half a percentage point in response to first-quarter results that the telecom giant announced before the market opened on April 24.
First-quarter
Why AT&T Stock Ticked Up Today
Shares of AT&T (NYSE: T) were moving higher today. Investors applauded its latest quarterly results as the telecom giant easily beat expectations on the top and bottom lines.
As a result, the
AT&T; (T) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
AT&T (NYSE: T)Q1 2024 Earnings CallApr 24, 2024, 8:30 a.m. ET
Operator
Source Fool.com